Goldman Sachs Australia Gold, Lithium and Uranium Coverage Summary: stronger upside in gold names and WA1, while some lithium and uranium names are rated Sell

Overview

This is a Goldman Sachs coverage summary note covering a basket of Australian gold, lithium and uranium equities, dated July 10, 2026. It is not a single-company deep dive, but a cross-commodity coverage digest focused on stock ratings, 12-month target prices, P/NAV, NTM EV/EBITDA, dividend yield, TSR, FCF yield, commodity-price sensitivity and global peer reserve comparisons.

Core views

The key message is that resource stocks should be selected based on commodity specialization and stock-specific valuation dispersion. In the gold sector, NEM, NST, BGL, RMS, WGX and PNR are listed as Buy, indicating comparatively clear positive risk-reward. In lithium, PLS and MIN are listed as Sell, while IGO, LTR and CXO are Neutral, reflecting that lithium price and earnings leverage remain cautious. In uranium, PDN is Sell, and DYL and BOE are Neutral. WA1, as a niobium name, is listed as Buy and has the highest target-price upside in the table.

Analysis framework

The report uses a cross-company, cross-commodity relative valuation framework: it first presents covered stocks by rating, target price, NAV, P/NAV, EV/EBITDA, dividend and FCF yield, then compares GS base-case commodity prices versus spot prices, FX and FactSet consensus, and finally shows production, costs, EBITDA, FCF, reserve/resource metrics and global peer EV/resource comparisons by lithium, uranium and gold.

Methodology notes

• Valuation comparisonP/NAV and NTM EV/EBITDA

  Relative valuation versus NAV premium/discount

  The report uses P/NAV to measure the stock's premium or discount to net asset value, and NTM EV/EBITDA to compare operating valuation multiples across different resource companies.

• Scenario analysisGS base-case vs spot pricing and FX

  Commodity-price and FX sensitivity

  The report compares Goldman Sachs commodity price forecasts with spot assumptions and FX assumptions to observe how earnings, FCF yield, valuation and leverage metrics change across price scenarios.

• Cash flow qualityFCF yield and production growth

  Balance of free cash flow and growth

  The report combines average FCF yield with production growth and EBITDA CAGR to assess earnings quality and sustainability of growth for resource companies.

• Resource comparisonEV/Resource and EV/Production

  Valuation by resource unit

  The report presents EV/resource, EV/production and reserve-reserve life by lithium, uranium and gold to compare resource quality, scale and market pricing across projects and companies.

• Goldman proprietary frameworkGS Factor Profile and M&A Rank

  Factor profile and acquisition likelihood score

  The report discloses part of GS Factor Profile, which characterizes stock attributes across growth, financial returns, valuation multiples and composite scores, while M&A Rank uses a 1-to-3 score to gauge the probability a company becomes a takeover target.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Gold

  A core coverage sector, with the Buy list mainly concentrated in gold equities, including NEM, NST, BGL, RMS, WGX and PNR.

  Strengths

  Multiple gold names show positive upside under target-price metrics, and the report also shows production, costs, EBITDA, FCF, hedging prices, reserves and resource-volume indicators.

  Weaknesses

  Some gold names such as GGP are rated Sell, while RRL, VAU and GMD are Not Rated, indicating clear valuation and quality dispersion within the gold group.

  Comparison

  The report compares EV/production, EV/resource, EBITDA per oz, FCF per oz and global peer reserve maps in A$/oz or US$/oz terms.

  Risks

  Gold-price volatility, divergences between hedging assumptions and spot, cost inflation, ore grade and mine-life changes can all affect valuation.

• Lithium

  The coverage includes lithium miners and diversified lithium-linked names, including IGO, PLS, LTR, CXO and MIN, among others.

  Strengths

  The report provides detailed comparisons of spodumene, lithium carbonate and lithium hydroxide pricing, as well as LCE resources and production, to assess price elasticity.

  Weaknesses

  PLS and MIN are rated Sell, reflecting insufficient target-price upside or mismatched valuation and earnings risk for some lithium names.

  Comparison

  The report compares Chinese CIF and Australian FOB spodumene prices, SGX futures, BMX auctions, EV/tonne LCE resources and adjusted EV/EBITDA.

  Risks

  Divergence between lithium price forecasts and spot, differences in project stage, mixed non-lithium exposure and the fact that reserve metrics do not fully represent project economics or development timelines.

• Uranium

  The coverage includes uranium names PDN, DYL and BOE, and includes Australian uranium projects plus global uranium resource comparisons.

  Strengths

  The report shows uranium production, realized price, cash cost, AISC, S/D model outputs and reserve-unit valuation.

  Weaknesses

  PDN is rated Sell, while DYL and BOE are Neutral, indicating inconsistency in upside potential and fundamental quality within the sector.

  Comparison

  The report compares uranium resource, production, cost and global peer EV/resource using A$/lb or US$/lb metrics.

  Risks

  Uranium price, project timelines, cost curve shape, regulatory environment and supply-demand-model assumption changes can materially affect valuation.

• Niobium / WA1

  WA1, the niobium name, is listed as Buy in the coverage summary.

  Strengths

  The table shows WA1 current price 12.38, 12-month target 27.30, corresponding to around 121% upside, the highest upside among all coverage names.

  Weaknesses

  Several conventional operating indicators in the table are blank, suggesting that project or company stage may limit comparability for standard EV/EBITDA and FCF multiples.

  Comparison

  Compared with established gold, lithium and uranium producers, WA1 relies more on NAV and target-price scenarios than on near-term cash-flow multiples.

  Risks

  Project execution, resource confirmation, commodity market pricing and valuation-assumption changes may amplify volatility.

Key data

• Report pricing date2026-07-10Cover states Priced as of 10 July 2026, and the appendix also lists As of July 10, 2026.
• Buy namesNEM, NST, BGL, RMS, WGX, PNR, WA1The Buy list is shown in the coverage summary on page 2.
• Sell namesPLS, MIN, GGP, PDNThe Sell list is shown in the coverage summary on page 2.
• Top upside namesWA1 about 121%, RMS about 57%-58%, PNR about 58%, WGX about 45%, BGL about 30%The coverage summary table calculates upside potential from current price versus 12-month target price.
• Core gold buysNEM target 161.30, NST target 23.20, BGL target 1.70, RMS target 4.80, WGX target 6.95, PNR target 3.35Currency and per-share basis are as shown in the table.
• Lithium-related ratingsIGO Neutral, PLS Sell, LTR Neutral, CXO Neutral, MIN SellThe report gives differentiated ratings for lithium-related companies and shows spodumene and LCE metrics and lithium price references.
• Uranium-related ratingsPDN Sell, DYL Neutral, BOE NeutralThe report presents uranium price, production, cash cost, AISC and global uranium reserve comparisons.
• Key valuation metricsP/NAV, NTM EV/EBITDA, FCF Yield, Dividend Yield, TSR YieldThese metrics are repeatedly used across the coverage summary and sector-specific tables.

Impact & implications

For portfolio construction, the report implies that resource stock allocations should not be driven by a single commodity call alone. Selection should combine commodity-price scenarios, target-price upside, NAV discount, free-cash-flow yield and resource asset quality. Gold names represent the largest portion of the Buy list, suggesting gold has more attractive risk-reward in this coverage set. Lithium and uranium emphasize price assumptions, costs and valuation sensitivity, with some names still rated Sell despite resource exposure.

Risks

• Divergence between commodity-price forecasts and spot prices can alter target prices, NAV, EBITDA and FCF yield.
• Changes in FX assumptions can materially affect conversion of Australian resource-company revenue, costs and valuations.
• Differences in project stage, ore grade, cost curves and production ramp rates across lithium, uranium and gold companies reduce cross-peer comparability.
• Some tables indicate that the latest commodity team price updates may not yet be fully reflected in company models.
• Resource volume or EV/resource metrics alone cannot represent project economics, development schedule or asset growth potential.
• The report is a compendium coverage summary; detailed regulatory disclosures and the latest company-level ratings and target prices should be checked in each company’s latest standalone report.

What to watch

• Subsequent Goldman Sachs commodity-team updates to gold, lithium and uranium price and FX assumptions.
• Whether the gap between GS base-case, spot prices and FactSet consensus narrows or widens.
• For gold equities: FCF yield, hedging price, unit cost and reserve-life changes.
• The linkage between Chinese CIF, Australian FOB, SGX futures and BMX-auction lithium prices.
• Uranium supply-demand modeling, progress on Australian uranium projects and uranium cost curves.
• Execution progress and valuation realization for high-upside Buy names such as WA1, RMS, PNR, WGX and BGL.